Home › Kidney Cancer (Renal Cell Carcinoma) › North Dakota › Fargo
Kidney Cancer (Renal Cell Carcinoma) clinical trials in Fargo, ND
3 studies for Kidney Cancer (Renal Cell Carcinoma) are looking for participants at sites in and around Fargo (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Essentia Health Cancer Center-South University Clinic, Fargo
- Sanford South University Medical Center, Fargo
- Southpointe-Sanford Medical Center Fargo, Fargo
- and 3 more
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
RecruitingPhase 2
- Sanford Broadway Medical Center, Fargo
- Sanford Roger Maris Cancer Center, Fargo
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
RecruitingPhase 3
- Essentia Health Cancer Center-South University Clinic, Fargo
- Sanford Broadway Medical Center, Fargo
- Sanford Roger Maris Cancer Center, Fargo
Kidney Cancer (Renal Cell Carcinoma) trials in other cities
- Houston, TX35 studies
- New York City, NY27 studies
- Dallas, TX23 studies
- Nashville, TN23 studies
- St. Louis, MO23 studies
- Los Angeles, CA20 studies
- Boston, MA16 studies
- Baldwin Park, CA16 studies
- Philadelphia, PA15 studies
- Pittsburgh, PA15 studies
- Queens, NY15 studies
- Cleveland, OH14 studies
Other studies in Fargo
- Non-Small Cell Lung Cancer15 studies
- Lung Cancer13 studies
- Cancer (all types)10 studies
- Melanoma9 studies
- Obesity9 studies
- Overweight8 studies
- Prostate Cancer8 studies
- Breast Cancer7 studies
- Colorectal Cancer7 studies
- Type 2 Diabetes6 studies
- Pancreatic Cancer6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.